CRH and hematologic disorder: Pathways unique to the PNT2 LMF-treated group were related to corticotropin-releasing hormone signalling pathway, hematopoietic system disease, hemidesmosome assembly, cell junction organisation, and the uptake of dietary cobalamin into enterocytes.